Enhancement of antibody production by the addition of Coenzyme-Q10
- 260 Downloads
Recently, there has been a growing demand for therapeutic monoclonal antibodies (MAbs) on the global market. Because therapeutic MAbs are more expensive than low-molecular-weight drugs, there have been strong demands to lower their production costs. Therefore, efficient methods to minimize the cost of goods are currently active areas of research. We have screened several enhancers of specific MAb production rate (SPR) using a YB2/0 cell line and found that coenzyme-Q10 (CoQ10) is a promising enhancer candidate. CoQ10 is well known as a strong antioxidant in the respiratory chain and is used for healthcare and other applications. Because CoQ10 is negligibly water soluble, most studies are limited by low concentrations. We added CoQ10 to a culture medium as dispersed nanoparticles at several concentrations (Q-Media) and conducted a fed-batch culture. Although the Q-Media had no effect on cumulative viable cell density, it enhanced SPR by 29%. In addition, the Q-Media had no effect on the binding or cytotoxic activity of MAbs. Q-Media also enhanced SPR with CHO and NS0 cell lines by 30%. These observations suggest that CoQ10 serves as a powerful aid in the production of MAbs by enhancing SPR without changing the characteristics of cell growth, or adversely affecting the quality or biological activity of MAbs.
KeywordsAntioxidant Coenzyme-Q10 Chinese hamster ovary (CHO) 8-hydroxy-2′-deoxyguanosine Monoclonal antibodies NS0 Specific production rate YB2/0 Enhancer Productivity
Culture media supplemented with dispersed nanoparticles of Q10
Specific MAb production rate (pg cell−1 d−1)
We would like to thank Dr. Kazuyasu Nakamura, Ms. Masako Wakitani, and Mr. Noriyuki Takahashi for their expert analysis, and Mr. Hiroshi Takasugi, Dr. Kazuhisa Uchida, Dr. Jun Yamaya, and Dr. Mitsuo Sato for helpful discussions and encouragement.
- Chello M, Mastroroberto P, Romano R et al (1996) Protection by coenzyme Q10 of tissue reperfusion injury during abdominal aortic cross-clamping. J Cardiovasc Surg (Torino) 37:229–235Google Scholar
- Kogan A, Syrkin AL, Drinitsina SV et al. (1999) The antioxidant protection of the heart by coenzyme Q10 in stable stenocardia of effort. Patol Fiziol Eksp Ter:16–19Google Scholar
- Konno Y, Aoki M, Takasugi H et al. (2001) Process for producing substance. WO/2003/046174Google Scholar
- Konno Y, Sakai N, Sakai K et al. (2006) Method for production of substance. WO/2007/049567Google Scholar
- Mancuso MOD, Volpi L, Calsolaro V, Siciliano G. (2010) Coenzyme Q10 in neuromuscular and neurodegenerative disorders. Curr Drug Targets 11:111–121Google Scholar
- Nakamura K, Hanibuchi M, Yano S et al (1999) Apoptosis induction of human lung cancer cell line in multicellular heterospheroids with humanized antiganglioside GM2 monoclonal antibody. Cancer Res 59:5323–5330Google Scholar
- Ogawa T, Konno Y, Akashi N et al. (1999) Process for producing polypeptide. WO/2001/029246Google Scholar
- Shinkawa T, Nakamura K, Yamane N et al (2003) The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem 278:3466–3473CrossRefGoogle Scholar